Pathology Instruments Market by Instruments (Centrifuges, Cytometers, Digital Pathology Solutions), Application (Anatomic Pathology, Clinical Pathology, Molecular Pathology), End-User - Global Forecast 2024-2030
The Pathology Instruments Market size was estimated at USD 7.46 billion in 2023 and expected to reach USD 7.94 billion in 2024, at a CAGR 7.11% to reach USD 12.07 billion by 2030.
Pathology instruments are specialized tools and equipment used in the examination of tissues and body fluids to diagnose diseases. These instruments include microtomes for slicing tissue specimens, histology stain systems for color-coding cells and tissue components, and analyzers that measure specific blood or urine sample markers. Pathology instruments are applied in histopathology, cytopathology, molecular pathology, and forensic pathology, among other fields. An increase in chronic diseases worldwide contributes to the need for diagnostic services and necessitates the deployment of highly efficient pathology instruments. Furthermore, growing healthcare expenditure by governments and support for deploying advanced pathology solutions can lead to increased investments in pathology facilities, aiding the growth of the market. However, the high costs of advanced pathology instruments may hinder their adoption. Additionally, errors associated with pathology instruments and difficulties in handling the instruments can further present challenges to the widespread utilization of pathology instruments. However, key players are investing in the integration of digital pathology systems and instruments with AI, and machine learning offers to improve and ease the adoption of pathology instruments. These systems can handle large data sets, improve diagnostic accuracy, and enhance workflow efficiency. Furthermore, collaborating with healthcare providers to develop integrated systems that connect pathology instruments with other medical devices and electronic health records can provide new avenues of growth for the industry.
Regional Insights
The Americas region, particularly the US and Canada, features a robust healthcare infrastructure characterized by the presence of several major players in the healthcare industry, which has driven the growth of the pathology instruments market. The region is also involved in the constant exploration of advanced digital technologies, including artificial intelligence (AI), machine learning (ML), and big data analytics, that have significantly enhanced the functionality and performance of pathology instruments. Stringent regulations by the European Union on in-vitro diagnostics and a well-established healthcare infrastructure foster market growth. Frequent collaboration between private and public entities to propel diagnostics capabilities has further led to constant innovations in pathology solutions and instruments. The Asia-Pacific region is exhibiting rapid growth in the pathology instruments market, with countries such as China, Japan, and India leading the expansion. China's market is burgeoning, fueled by large-scale healthcare reforms and growing investment in healthcare infrastructure. Additionally, the Chinese government's focus on public health and preventive healthcare measures adds to the increased demand for pathology services.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Pathology Instruments Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Rising prevalence of chronic diseases worldwide and the need for diagnostic information
- Expansion of diagnostics and pathology laboratories
- Government initiatives to improve pathology services and the rise of digital pathology solutions
- Market Restraints
- Instrument-related errors and potential accuracy issues
- Market Opportunities
- Advancements to improve the performance of pathology instruments
- Adoption of pathology tools in drug discovery and patient preference for personalized diagnosis
- Market Challenges
- Difficulties in handling pathology instruments and safety issues of pathology tools
- Market Segmentation Analysis
- Instruments: Efforts by key manufacturers to advance the capabilities of hematology instruments
- Application: R&D initiatives to support the innovations in molecular pathology
- End-User: Expansion of diagnostic laboratories across the world to serve the critical demand for disease detection
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pathology Instruments Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pathology Instruments Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- Metrion Biosciences Closes GBP 3.5 Million (USD 4.7 Million) Financing to Support Lab Expansion
Metrion Biosciences, the UK-based company specializing in ion channel research and drug discovery, announced the successful investments of GBP 3.5 million (USD 4.7 million) in fresh equity financing. This strategic capital raise marks a pivotal step for Metrion Biosciences, poised to bolster its innovation and growth within the pathology instruments sector.
PerkinElmer Acquires Life Sciences Firm Covaris
PerkinElmer successfully acquired Covaris, a company specializing in life science technology. This acquisition catalyzes Covaris's expansion trajectory while enriching PerkinElmer's portfolio, particularly within the high-demand diagnostics market. Covaris's proficiency in next-generation sequencing (NGS) is a significant boon for PerkinElmer as it positions itself at the forefront of precision medicine.
Versant Diagnostics Partners with Dahl-Chase Pathology and Diagnostic Groups
Versant Diagnostics, an independent provider of physician services in the realm of anatomic pathology, announced a strategic collaboration with Dahl-Chase Pathology Associates and Dahl-Chase Diagnostic Services. This union is set to fortify Versant Diagnostics' service portfolio. Dahl-Chase is acclaimed for delivering comprehensive diagnostic solutions that span surgical pathology, histology, immunohistochemistry, cytology, flow cytometry, and molecular diagnostics. The collaboration is poised to enhance patient care by leveraging Dahl-Chase's expansive expertise with a mutual commitment to innovation and excellence in pathology services.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pathology Instruments Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Pathology Instruments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Amos Scientific Pty. Ltd., Becton, Dickinson and Company, Bio SB Inc., Bio-Genex Laboratories, Bio-Rad Laboratories, Inc., BRAND GMBH + CO KG, Carl Zeiss AG, Danaher Corporation, Diapath S.p.A., Diatron Group by STRATEC SE, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Hamamatsu Photonics K.K., Hamilton Company, Hologic, Inc., Horiba Corporation, Illumina Inc., Jinan Olabo Technology Co., Ltd., Koninklijke Philips N.V., Merck KGaA, Mikroscan Technologies, Inc., Nihon Kohden Corporation, Olympus Corporation, PerkinElmer Inc., PHC Holdings Corporation, QIAGEN N.V., RWD Life Science Co., Ltd., Sakura Finetek Japan Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., VOGEL MedTec GmbH, and Waters Corporation.
Market Segmentation & Coverage
This research report categorizes the Pathology Instruments Market to forecast the revenues and analyze trends in each of the following sub-markets:- Instruments
- Centrifuges
- Cytometers
- Digital Pathology Solutions
- Digital Pathology Systems
- Hematology Instruments
- Immunohistochemistry (IHC) Instruments
- Incubators
- Microtomes
- Staining Machines
- Tissue Processors
- Application
- Anatomic Pathology
- Clinical Pathology
- Molecular Pathology
- End-User
- Academic & Research Institutes
- Diagnostic Laboratories
- Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of chronic diseases worldwide and the need for diagnostic information
- 5.1.1.2. Expansion of diagnostics and pathology laboratories
- 5.1.1.3. Government initiatives to improve pathology services and the rise of digital pathology solutions
- 5.1.2. Restraints
- 5.1.2.1. Instrument-related errors and potential accuracy issues
- 5.1.3. Opportunities
- 5.1.3.1. Advancements to improve the performance of pathology instruments
- 5.1.3.2. Adoption of pathology tools in drug discovery and patient preference for personalized diagnosis
- 5.1.4. Challenges
- 5.1.4.1. Difficulties in handling pathology instruments and safety issues of pathology tools
- 5.2. Market Segmentation Analysis
- 5.2.1. Instruments: Efforts by key manufacturers to advance the capabilities of hematology instruments
- 5.2.2. Application: R&D initiatives to support the innovations in molecular pathology
- 5.2.3. End-User: Expansion of diagnostic laboratories across the world to serve the critical demand for disease detection
- 5.3. Market Trend Analysis
- 5.3.1. Growing emphasis on digital pathology instruments along with a strong foothold of key market players of the Americas
- 5.3.2. Expanding the number of clinical laboratory tests coupled with ongoing advancements in pathology instruments in the APAC region
- 5.3.3. Strong presence of established regional players in the EMEA pathology instrument market supporting the development of advanced and digitalized pathology laboratories in the region
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. Pathology Instruments Market, by Instruments
- 6.1. Introduction
- 6.2. Centrifuges
- 6.3. Cytometers
- 6.4. Digital Pathology Solutions
- 6.5. Digital Pathology Systems
- 6.6. Hematology Instruments
- 6.7. Immunohistochemistry (IHC) Instruments
- 6.8. Incubators
- 6.9. Microtomes
- 6.10. Staining Machines
- 6.11. Tissue Processors
- 7. Pathology Instruments Market, by Application
- 7.1. Introduction
- 7.2. Anatomic Pathology
- 7.3. Clinical Pathology
- 7.4. Molecular Pathology
- 8. Pathology Instruments Market, by End-User
- 8.1. Introduction
- 8.2. Academic & Research Institutes
- 8.3. Diagnostic Laboratories
- 8.4. Hospitals
- 9. Americas Pathology Instruments Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Pathology Instruments Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Pathology Instruments Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Metrion Biosciences Closes GBP 3.5 Million (USD 4.7 Million) Financing to Support Lab Expansion
- 12.3.2. PerkinElmer Acquires Life Sciences Firm Covaris
- 12.3.3. Versant Diagnostics Partners with Dahl-Chase Pathology and Diagnostic Groups
- 12.3.4. 3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics
- 12.3.5. Abbott’s Alinity h-series Haematology System Receives FDA Approval
- 12.3.6. Discovery Life Sciences Boosts Clinical Trials with Full-Spectrum Clinical Flow Cytometry
- 12.3.7. Nikon introduces the ECLIPSE Ui Upright Digital Microscope
- 12.3.8. Siemens Healthineers Launches Next-gen Hematology Analyzers
- 12.3.9. Siemens Healthineers to Unveil Next-gen Hematology Analyzers at EuroMedLab 2023
- 12.3.10. Leica Biosystems Launches BOND-PRIME Advanced Staining Solution
- 12.3.11. Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
- 12.3.12. Hamamatsu and Siemens Healthineers Announce the Distribution of the Whole Slide Scanners to Clinical Markets
- 12.3.13. Clarapath Acquires Crosscope and Combines Tissue Processing Robotics with AI-Powered Digital Pathology for Building the Lab of the Future
- 12.3.14. Siemens Healthineers Launch Laboratory Equipment R&D Centre In Swords
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook